Selection of a single antibody-forming cell clone and its propagation in syngeneic mice.
نویسندگان
چکیده
A single antibody-forming cell clone has been selected from primed mice by sequential transfer of limited numbers of spleen cells into irradiated syngeneic mice. The original spleen cell donors had been immunized with dinitrophenylated bovine gamma globulin. Specific antibody molecules in sera of recipient mice were separated by isoelectric focusing on polyacrylamide gels and visualized by (131)I-hapten binding and autoradiography. This method provided a marker for antibody-forming cells derived from a single cell clone. This report describes the history of one clone of cells (E9) producing IgG antibody to dinitrophenyl. Clone E9 is long-lived and has been maintained for five transplant generations (over 6 months) by serial transfer of spleen cells into irradiated syngeneic mice. Clone E9 has the following properties: (1) Antibody production strictly depends on antigen, presented either in vivo or in vitro; (2) Induction of E9 anti-dinitrophenyl shows specificity for the carrier protein; (3) Antibody is produced in amounts (2-3 mg/ml serum) comparable with myeloma-protein production by murine plasmacytomas; (4) In the absence of antigen, memory cells have a lifetime exceeding 28 days.
منابع مشابه
CD38 MOLECULE-A MULTILINEAGE GLYCOPROTEIN AND ITS UNIQUE EXPRESSION ON PLASMA CELLS
A hybridoma clone designated 6G5 has been selected by fusion of mouse myeloma cell line Ag. 8653 with spleen cells from mice immunized with human peripheral blood mononuclear cells (PBMC). The antibody produced by this clone was found to be strongly reactive with four human B-cell lines in the conventional immunological assays. Despite the fact that expression of most B cell-associated mar...
متن کاملMonoclonal Antibody Production Against Vimentin by Whole Cell Immunization in a Mouse Model
Background: Pancreatic carcinoma is the fourth-leading cause of cancer death in the United States and due to its late presentation, only few patients would be candidates for the curative treatment of pancreactomy. Monoclonal antibodies have brought hope to targeted therapy.Objectives: To identify new biomarkers, a panel of monoclonal antibodies was genera...
متن کاملSelection and Evaluation of Specific Single Chain Antibodies against CD90, a Marker for Mesenchymal and Cancer Stem Cells
Background: CD90, a membrane-associated glycoprotein is a marker used to identify mesenchymal stem cells (MSCs). Recent studies have introduced CD90, which induces tumorigenic activity, as a cancer stem cell (CSC) marker in various malignancies. Blocking CD90 activity with anti-CD90 monoclonal antibodies enhanced anti-tumor effects. To date, highly specific antibody single-chain variable fragme...
متن کاملA Novel mAb against a Human CD34 Peptide Reacts with the Native Protein on CD34+ Cells
Background: Human CD34 is a transmembrane glycoprotein which is expressed in human hematopoietic stem cells (HSCs) and the small- vessel endothelial cells of a variety of tissues. CD34 plays a critical role as a marker for diagnosis and classification of leukemia. Anti CD34 antibodies are used for isolation and purification of HSCs from bone marrow, peripheral blood and cord blood. Objective: ...
متن کاملO 24: Functional Role of The K2p Potassium Channel Task-3 in A Syngeneic Murine Glioma Model
To investigate the effects of the two-pore-domain potassium (K2P) channel TASK-3 in a syngeneic murine model for malignant glioma. Malignant or high-grade glioma (WHO grade III and IV) are the most common and most aggressive primary brain tumors in adults. Despite aggressive multimodal therapy, the outcome of patients with malignant glioma remains poor. However, recent phase I and II trials hav...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Proceedings of the National Academy of Sciences of the United States of America
دوره 67 3 شماره
صفحات -
تاریخ انتشار 1970